Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

Brent Wilhelm, Senior Vice President of Global Supply Chain, Cencora

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory

ByBrent Wilhelm,Zachary Zubulake

July 16th 2026

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

ByBrian Drapeau

July 16th 2026

Topical Corticosteroid Bioequivalence Guidance Ends 30-Year Wait

The Implications of the FDA’s New Finalized Guidance Documents

ByZachary Zubulake

July 16th 2026

Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching

ByManish Garg, PMP, PSM

July 16th 2026

FDA concept. Concept of the Food and Drug Administration. Magnifier glass, folder and clock | Image credit: © Sviatlana - © Sviatlana-stock.adobe.com

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

ByFeliza Mirasol,Jeffrey C. Mocny,Anna McMahon

July 15th 2026

Good Work and True: USP Prepares for Convention 2005

Articles in this issue

Related Content

Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory

Can Governance-by-Design Make AI Compliant in Pharma? (Part II)

The Implications of the FDA’s New Finalized Guidance Documents

Midyear 2026 Check-In: AI, Supply Chains, and the NDC-12 Story Nobody's Watching

Using Risk-Based Quality Frameworks to Fast-Track Biopharma Development: A Q&A with Abzena’s Jeffrey C. Mocny and Cellares’ Anna McMahon

Trending on Pharmaceutical Technology

FDA Activity Round Up – July 2026

Using Automation to Enhance Pharmaceutical Manufacturing

Hidden Cost Drivers in Oligonucleotide Manufacturing

EMA and EU Innovation Agency Deepen Ties to Speed Up Drug Development

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part One